istock-104821184
Chris Ryan / iStockphoto.com
12 November 2018Americas

BMS company not required to pay damages in trade secrets case

A jury has said that Flexus Biosciences, a company owned by Bristol-Myers Squibb (BMS), does not need to pay damages despite being liable for trade secrets misappropriation.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk